Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-02

Clinical Trial Update: Concurrent Azeliragon With Craniospinal Irradiation [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating azeliragon in combination with craniospinal irradiation for patients with high-grade glioma and leptomeningeal metastasis; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azeliragon (Azeliragon)

Snippet

Sponsor: NYU Langone Health | Conditions: Solid Tumor, High-grade Glioma | Phase 1 | Status: RECRUITING